| Date: | 03/06/2020 |
|---|---|
| Organization: | Massachusetts Health Policy Commission |
| Regulatory Authority: |
M.G.L. c. 6D, § 8A M.G.L. c. 118E, § 12A |
| Official Version: | Purchase the official version |
This regulation specifies the procedures by which the Commission may review information relative to a Referred Manufacturer's pricing practices and determine whether its pricing of a Drug is unreasonable or excessive in relation to the Drug's value.